Medexus Pharmaceuticals Stock Market Value
| MEDXF Stock | USD 2.10 0.04 1.87% |
| Symbol | Medexus |
Medexus Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Medexus Pharmaceuticals' otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Medexus Pharmaceuticals.
| 06/09/2024 |
| 12/31/2025 |
If you would invest 0.00 in Medexus Pharmaceuticals on June 9, 2024 and sell it all today you would earn a total of 0.00 from holding Medexus Pharmaceuticals or generate 0.0% return on investment in Medexus Pharmaceuticals over 570 days. Medexus Pharmaceuticals is related to or competes with Earth Science, 1CM, and Vext Science. Medexus Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada and the United States More
Medexus Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Medexus Pharmaceuticals' otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Medexus Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.77 | |||
| Information Ratio | (0.01) | |||
| Maximum Drawdown | 17.36 | |||
| Value At Risk | (4.50) | |||
| Potential Upside | 5.45 |
Medexus Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Medexus Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Medexus Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Medexus Pharmaceuticals historical prices to predict the future Medexus Pharmaceuticals' volatility.| Risk Adjusted Performance | 0.0182 | |||
| Jensen Alpha | 0.0451 | |||
| Total Risk Alpha | (0.23) | |||
| Sortino Ratio | (0.01) | |||
| Treynor Ratio | (0.25) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Medexus Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Medexus Pharmaceuticals Backtested Returns
At this point, Medexus Pharmaceuticals is risky. Medexus Pharmaceuticals has Sharpe Ratio of 0.0304, which conveys that the firm had a 0.0304 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Medexus Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please verify Medexus Pharmaceuticals' Mean Deviation of 2.25, risk adjusted performance of 0.0182, and Downside Deviation of 2.77 to check out if the risk estimate we provide is consistent with the expected return of 0.0796%. Medexus Pharmaceuticals has a performance score of 2 on a scale of 0 to 100. The company secures a Beta (Market Risk) of -0.15, which conveys not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Medexus Pharmaceuticals are expected to decrease at a much lower rate. During the bear market, Medexus Pharmaceuticals is likely to outperform the market. Medexus Pharmaceuticals right now secures a risk of 2.62%. Please verify Medexus Pharmaceuticals downside variance, day median price, and the relationship between the treynor ratio and kurtosis , to decide if Medexus Pharmaceuticals will be following its current price movements.
Auto-correlation | 0.17 |
Very weak predictability
Medexus Pharmaceuticals has very weak predictability. Overlapping area represents the amount of predictability between Medexus Pharmaceuticals time series from 9th of June 2024 to 21st of March 2025 and 21st of March 2025 to 31st of December 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Medexus Pharmaceuticals price movement. The serial correlation of 0.17 indicates that over 17.0% of current Medexus Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.17 | |
| Spearman Rank Test | 0.04 | |
| Residual Average | 0.0 | |
| Price Variance | 0.03 |
Medexus Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Medexus Pharmaceuticals otc stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Medexus Pharmaceuticals' otc stock expected returns. We can calculate the autocorrelation of Medexus Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Medexus Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the otc stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Medexus Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Medexus Pharmaceuticals otc stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Medexus Pharmaceuticals otc stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Medexus Pharmaceuticals otc stock over time.
Current vs Lagged Prices |
| Timeline |
Medexus Pharmaceuticals Lagged Returns
When evaluating Medexus Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Medexus Pharmaceuticals otc stock have on its future price. Medexus Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Medexus Pharmaceuticals autocorrelation shows the relationship between Medexus Pharmaceuticals otc stock current value and its past values and can show if there is a momentum factor associated with investing in Medexus Pharmaceuticals.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Other Information on Investing in Medexus OTC Stock
Medexus Pharmaceuticals financial ratios help investors to determine whether Medexus OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medexus with respect to the benefits of owning Medexus Pharmaceuticals security.